In parallel, a reduction in the “protective factor” angiotensinogen (AGT), required for intact localization and function of occludin, has been detected in astrocytes activated in vitro by pro-inflammatory cytokines, as well as in perivascular astrocytes within MS lesions [70]. This evidence concerns the gene AGT and myeloid sarcoma.